methylselenic acid has been researched along with mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin in 1 studies
| Studies (methylselenic acid) | Trials (methylselenic acid) | Recent Studies (post-2010) (methylselenic acid) | Studies (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Trials (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Recent Studies (post-2010) (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) |
|---|---|---|---|---|---|
| 144 | 1 | 68 | 69 | 0 | 42 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharyya, RS; Feldman, D; Husbeck, B; Knox, SJ | 1 |
1 other study(ies) available for methylselenic acid and mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin
| Article | Year |
|---|---|
Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action.
Topics: Acetylcysteine; Androgen Receptor Antagonists; Dose-Response Relationship, Drug; Down-Regulation; Glutathione; Humans; Male; Metalloporphyrins; Metribolone; Organoselenium Compounds; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Receptors, Steroid; Signal Transduction; Sodium Selenite; Sp1 Transcription Factor; Superoxides; Tumor Cells, Cultured | 2006 |